Authors:
RUMMEL M
KNUTH A
HOSSFELD D
BERGMANN L
HOELZER D
MITROU PS
Citation: M. Rummel et al., 2-CDA IN THE TREATMENT OF PREVIOUSLY UNTREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - FINAL RESULTS, Annals of oncology, 9, 1998, pp. 517-517
Authors:
KARAKAS T
MAURER U
WEIDMANN E
MIETHING CC
HOELZER D
BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Annals of oncology, 9(2), 1998, pp. 159-165
Authors:
BANGERTER M
MOOG F
BUCHMANN I
KOTZERKE J
GRIESSHAMMER M
HAFNER M
ELSNER K
FRICKHOFEN N
RESKE SN
BERGMANN L
Citation: M. Bangerter et al., WHOLE-BODY 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE POSITRON-EMISSION-TOMOGRAPHY (FDC-PET) FOR ACCURATE STAGING OF HODGKINS-DISEASE, Annals of oncology, 9(10), 1998, pp. 1117-1122
Authors:
MARTIN H
ATTA J
FAUTH F
OTTMANN OG
OTT MG
WASSMANN B
BERGMANN L
KNAUF W
GRAMATZKI M
ZANDER A
BUNJES D
ARNOLD R
HOELZER D
Citation: H. Martin et al., AUTOLOGOUS BMT PBSCT IN PATIENTS WITH BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA/, Bone marrow transplantation, 21, 1998, pp. 5-5
Citation: M. Kroger et al., COMBINED INHALATION-THERAPY (CIT) MAY PREVENT TOXIC AIRWAY DAMAGE (TAD) AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 309-309
Authors:
BUNJES D
VONHARSDORF S
DUYSTER J
DUNCKER C
BERGMANN L
Citation: D. Bunjes et al., MYCOPHENOLATE MOFETIL - A POTENT NEW DRUG FOR THE TREATMENT OF CHRONIC GRAFT-VS-HOST-DISEASE WITH A FAVORABLE TOXICITY PROFILE, Bone marrow transplantation, 21, 1998, pp. 404-404
Citation: S. Kliesch et al., ALTERATION OF SERTOLI-CELL DIFFERENTIATION IN THE PRESENCE OF CARCINOMA IN-SITU IN HUMAN TESTES, The Journal of urology, 160(5), 1998, pp. 1894-1898
Authors:
KRAUTER J
PETER W
PASCHEBERG U
HEINZE B
BERGMANN L
HOELZER D
LUBBERT M
SCHLIMOK G
ARNOLD R
KIRCHNER H
PORT M
GANSER A
HEIL G
Citation: J. Krauter et al., DETECTION OF KARYOTYPIC ABERRATIONS IN ACUTE MYELOBLASTIC-LEUKEMIA - A PROSPECTIVE COMPARISON BETWEEN PCR FISH AND STANDARD CYTOGENETICS IN140 PATIENTS WITH DE-NOVO AML/, British Journal of Haematology, 103(1), 1998, pp. 72-78
Authors:
KRAUTER J
PASCHEBERG U
HEINZE B
BERGMANN L
HOELZER D
LUBBERT M
SCHLIMOK G
ARNOLD R
KIRCHNER H
PORT M
GANSER A
HELL G
Citation: J. Krauter et al., DETECTION OF CHROMOSOMAL-ABERRATIONS IN AML - COMPARISON OF RT-PCR FISH WITH STANDARD CYTOGENETICS/, British Journal of Haematology, 102(1), 1998, pp. 98-98
Authors:
BANGERTER M
MOOG F
GRIESSHAMMER M
RESKE SN
BERGMANN L
Citation: M. Bangerter et al., ROLE OF WHOLE-BODY FDG-PET IN PREDICTING RELAPSE IN RESIDUAL MASSES AFTER TREATMENT OF LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 148-148
Authors:
HEIL G
KRAUTER J
BERGMANN L
HOELZER D
HOSSFELD D
MERTELSMANN R
NOENS L
SCHLIMOK G
PORT M
SCHWAB G
GANSER A
Citation: G. Heil et al., RISK ADAPTED INDUCTION AND CONSOLIDATION THERAPY INCLUDING AUTOLOGOUSPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN ADULT DE-NOVO AML PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 150-150
Citation: L. Bergmann, THE RELEVANCE OF THE BCL-2 GENE AND WILMS-TUMOR GENE FOR THE LONG-TERM PROGNOSIS OF ACUTE MYELOID-LEUKEMIA, European journal of cancer, 33, 1997, pp. 1-1
Citation: C. Hartmann et L. Bergmann, SPECULAR MICROSCOPY - FROM SPECULATIVE TO SPECTACULAR MICROSCOPY, German journal of ophthalmology, 5(6), 1997, pp. 496-503
Authors:
GEISSLER RG
BERGMANN L
HACKER H
KNUPP B
WALKER B
HOELZER D
Citation: Rg. Geissler et al., SEVERE CENTRAL NERVOUS ADVERSE EFFECT OF INTRATHECAL CHEMOTHERAPY IN A 16-YR-OLD PATIENT WITH BURKITTS TYPE LYMPHOMA, European journal of haematology, 58(4), 1997, pp. 286-288
Authors:
WEIDMANN E
BRIEGER J
KARAKAS T
MAURER U
PASCHEBERG U
HOELZER D
MITROU PS
BERGMANN L
Citation: E. Weidmann et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW, FACTOR-INDEPENDENT ACUTEMYELOID-LEUKEMIA LINE DESIGNATED EI501, Leukemia, 11(5), 1997, pp. 709-713
Authors:
RUMMEL M
SCHENK M
RENNER C
KNUTH A
JOSTEN K
REINHARDT U
RENDENBACH B
PIELKEN HJ
WOJATSCHEK C
LENGFELDER E
MITROU PS
HOELZER D
BERGMANN L
Citation: M. Rummel et al., FLUDARABINE PLUS EPIRUBICIN IN UNTREATED OR MINIMAL PRETREATED PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS OF A PHASE-II STUDY, Onkologie, 20(4), 1997, pp. 328-331
Authors:
MAURER U
BRIEGER J
WEIDMANN E
MITROU PS
HOELZER D
BERGMANN L
Citation: U. Maurer et al., THE WILMS-TUMOR GENE IS EXPRESSED IN A SUBSET OF CD34(-REGULATED EARLY IN THE COURSE OF DIFFERENTIATION IN-VITRO() PROGENITORS AND DOWN), Experimental hematology, 25(9), 1997, pp. 945-950
Authors:
NAGASHIMA I
BERGMANN L
ALSINA AE
SCHWEIZER RT
Citation: I. Nagashima et al., AUXILIARY HETEROTOPIC PARTIAL LIVER-TRANSPLANTATION IN PIGS WITH ACUTE ISCHEMIC LIVER-FAILURE, Hepato-gastroenterology, 44(17), 1997, pp. 1426-1431
Authors:
BERGMANN L
MIETHING C
MAURER U
BRIEGER J
KARAKAS T
WEIDMANN E
HOELZER D
Citation: L. Bergmann et al., HIGH-LEVELS OF WILMS-TUMOR GENE (WT1) MESSENGER-RNA IN ACUTE MYELOID LEUKEMIAS ARE ASSOCIATED WITH A WORSE LONG-TERM OUTCOME, Blood, 90(3), 1997, pp. 1217-1225
Authors:
MAURER U
WEIDMANN E
KRAPOHL A
SCHNEIDER B
KARAKAS T
HOELZER D
BERGMANN L
Citation: U. Maurer et al., CONSTITUTIVE EXPRESSION OF WILMS-TUMOR GENE IN K562 DOES NOT ALTER TPA-INDUCED DIFFERENTIATION, Blood, 90(10), 1997, pp. 3775-3775
Authors:
KARAKAS T
MAURER U
WEIDMANN E
HOELZER D
BERGMANN L
Citation: T. Karakas et al., HIGH EXPRESSION OF BCL-2 MESSENGER-RNA AS A DETERMINANT OF POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 287-287